AU2001272103A1 - Stable cell lines resistant to apoptosis and nutrient stress and methods of making same - Google Patents
Stable cell lines resistant to apoptosis and nutrient stress and methods of making sameInfo
- Publication number
- AU2001272103A1 AU2001272103A1 AU2001272103A AU7210301A AU2001272103A1 AU 2001272103 A1 AU2001272103 A1 AU 2001272103A1 AU 2001272103 A AU2001272103 A AU 2001272103A AU 7210301 A AU7210301 A AU 7210301A AU 2001272103 A1 AU2001272103 A1 AU 2001272103A1
- Authority
- AU
- Australia
- Prior art keywords
- apoptosis
- methods
- cell lines
- making same
- stable cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000006907 apoptotic process Effects 0.000 title 1
- 235000015097 nutrients Nutrition 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0601—Invertebrate cells or tissues, e.g. insect cells; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/518,763 US7405038B1 (en) | 2000-03-03 | 2000-03-03 | Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
US09/518763 | 2000-03-03 | ||
PCT/US2001/006846 WO2001066696A2 (en) | 2000-03-03 | 2001-03-02 | Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001272103A1 true AU2001272103A1 (en) | 2001-09-17 |
Family
ID=24065395
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001272103A Abandoned AU2001272103A1 (en) | 2000-03-03 | 2001-03-02 | Stable cell lines resistant to apoptosis and nutrient stress and methods of making same |
Country Status (3)
Country | Link |
---|---|
US (1) | US7405038B1 (en) |
AU (1) | AU2001272103A1 (en) |
WO (1) | WO2001066696A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7223597B2 (en) | 2001-06-12 | 2007-05-29 | Pioneer Hi-Bred International, Inc. | Anti-apoptosis genes and methods of use thereof |
GB2394477B (en) * | 2002-08-22 | 2005-03-30 | Celltran Ltd | Cell culture |
US7537930B2 (en) | 2004-07-23 | 2009-05-26 | Immunomedics, Inc. | Mammalian cell lines for increasing longevity and protein yield from a cell culture |
WO2014159831A1 (en) * | 2013-03-13 | 2014-10-02 | Merck Sharp & Dohme Corp. | Adapted lepidopteran insect cells for the production of recombinant proteins |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09163983A (en) * | 1995-08-30 | 1997-06-24 | Hisamitsu Pharmaceut Co Inc | Efficient production of useful substance by apoptosis inhibition and cell |
AU9774998A (en) | 1997-09-19 | 1999-04-12 | Trustees Of The University Of Pennsylvania, The | Method for gene transfer using bcl2 and compositions useful therein |
EP1650307B1 (en) | 1999-09-27 | 2010-07-14 | Genentech, Inc. | Methods for making recombinant proteins using apoptosis inhibitors |
-
2000
- 2000-03-03 US US09/518,763 patent/US7405038B1/en not_active Expired - Fee Related
-
2001
- 2001-03-02 AU AU2001272103A patent/AU2001272103A1/en not_active Abandoned
- 2001-03-02 WO PCT/US2001/006846 patent/WO2001066696A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
US7405038B1 (en) | 2008-07-29 |
WO2001066696A3 (en) | 2002-03-14 |
WO2001066696A2 (en) | 2001-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1824600A (en) | Low oxygen culturing of cells | |
AU4336599A (en) | (in vitro) maintenance of hematopoietic stem cells | |
AU4094099A (en) | Production of megakaryocytes by co-culturing human mesenchymal stem cells with cd34+ cells | |
AU2001275148A1 (en) | Use of enzymes to reduce steep time and so2 requirements in a maize wet-milling process | |
HUP0202705A3 (en) | Methods and microorganisms or production of panto-compounds | |
GB2375351B (en) | Retrodifferentiation of cells to form undifferentiated cells | |
AU2001280954A1 (en) | Production of lysosomal enzymes in plants by transient expression | |
AU1478000A (en) | (in utero) transplantation of human mesenchymal stem cells | |
AU2002357079A1 (en) | Expression of lysosomal hydrolase in cells expressing pro-n-acetylglucosamine-1-phosphodiester alpha-n-acetyl glucosimanidase | |
EP2319528B8 (en) | Methods of increasing platelet and hematopoietic stem cell production | |
AU4829400A (en) | Battery grid and method of making | |
AU2001262697A1 (en) | Method of amplifying natural killer t cells | |
AU2002235168A1 (en) | Targeting pluripotent stem cells to tissues | |
AU2001247880A1 (en) | Methods to prepare and use epidermal stem cells | |
AU2002217795A1 (en) | Isolation procedure and optimized media solution to enhance long-term survival of cells | |
AU2002211444A1 (en) | Dynamic visualization of expressed gene networks in living cells | |
AU2003237983A1 (en) | Derivatives of azepine and thiazeran as interleukin converting enzyme inhibitors | |
AUPR041900A0 (en) | Manipulation of plant cell walls | |
AU2001272103A1 (en) | Stable cell lines resistant to apoptosis and nutrient stress and methods of making same | |
AU2001256555A1 (en) | New inhibotor of apoptosis of nerve cells | |
EP1109582A4 (en) | Methods to enhance and confine expression of genes | |
AU2001275897A1 (en) | Improvement of cell culture performance | |
AU2998300A (en) | Genetically altered mesenchymal stem cells and methods of use thereof | |
AU2003214160A1 (en) | Tissue specific signal-plexes to dedifferentiate and redifferentiate cells | |
AU2002226085A1 (en) | Active-site engineering of nucleotidyltransferases and enzymatic methods for the synthesis of natural and "unnatural" udp- and nucleotide sugars |